Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02195999 · ClinicalTrials.gov registry record
Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 9
- Enrollment target
NCT02195999 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 9 participants.
The verdict
NCT02195999 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This study seeks to develop and validate non-invasive assessments of cardiac and respiratory muscles with magnetic resonance imaging (MRI) to better predict the natural disease progression of Duchenne muscular dystrophy (DMD) in affected individuals over time, as well as determine whether peripheral skeletal muscle dysfunction can predict cardiopulmonary dysfunction. The central hypothesis is that non-invasive MRI measures of the heart, muscle, and peripheral skeletal muscles can sensitively predict future cardiopulmonary decline.
Interventions
- OTHER Magnetic Resonance Imaging (MRI)
- OTHER Echocardiogram
- OTHER Pulmonary Function Testing (PFT)
- OTHER Metabolic Exercise Testing using stationary bicycle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-12 |
| Est. Completion | 2019-03-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02195999
The ClinicalTrials.gov registry entry for NCT02195999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT02195999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02195999 about?
NCT02195999 is a clinical study titled "Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy". This study seeks to develop and validate non-invasive assessments of cardiac and respiratory muscles with magnetic resonance imaging (MRI) to better predict the natural disease progression of Duchenne muscular dystrophy (DMD) in affected individuals over time, as well as determine whether peripheral...
What is the current status of trial NCT02195999?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2013-12. Estimated completion is 2019-03-06.
What interventions are being tested in trial NCT02195999?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (OTHER), Echocardiogram (OTHER), Pulmonary Function Testing (PFT) (OTHER), Metabolic Exercise Testing using stationary bicycle (OTHER).
Who is sponsoring clinical trial NCT02195999?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.